Cleared Traditional

K940759 - FORTE ES (FDA 510(k) Clearance)

Class II Neurology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K940759 · Chattanooga Group, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1995
Decision
391d
Days
Class 2
Risk

K940759 is an FDA 510(k) clearance for the FORTE ES. Classified as Stimulator, Neuromuscular, External Functional (product code GZI), Class II - Special Controls.

Submitted by Chattanooga Group, Inc. (Hixson, US). The FDA issued a Cleared decision on March 16, 1995 after a review of 391 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5810 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Chattanooga Group, Inc. devices

Submission Details

510(k) Number K940759 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 18, 1994
Decision Date March 16, 1995
Days to Decision 391 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
243d slower than avg
Panel avg: 148d · This submission: 391d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GZI Stimulator, Neuromuscular, External Functional
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5810
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZI Stimulator, Neuromuscular, External Functional

All 60
Devices cleared under the same product code (GZI) and FDA review panel - the closest regulatory comparables to K940759.
Synchrony (20-3000)
K242704 · Synapse Biomedical, Inc. · Jun 2025
CIONIC NEURAL SLEEVE (NS-200)
K243828 · Cionic, Inc. · May 2025
Neuvotion NeuStim NN-01
K240632 · Neuvotion, Inc. · Nov 2024
MyndMove, MyndMove 2.0
K233006 · Myndtec, Inc. · Jun 2024
EvoWalk 1.0 System
K230997 · Evolution Devices, Inc. · Dec 2023
Cionic Neural Sleeve NS-100
K221823 · Cionic · Jul 2022